A recent study, published in Cell, suggests a systemically given small molecule could revive neural circuits in mice with spinal cord injury, restoring their ability to walk. The research, which was carried out at Boston Children’s Hospital (MA, USA), could complement regenerative therapies, aiding those with paralysis caused by spinal cord injury.
You may also be interested in...
Cell therapy weekly: Miltenyi Biotec and ATLATL co-found Shanghai cell and gene therapy center
Peek behind the paper: Preparing regenerative therapies for clinical application: proposals for responsible translation